The Fludarabine Shortage and Its Ripple Effects: Navigating the Crisis
The significant surge in oncology drug shortages in 2023 particularly affected essential chemotherapeutic drugs.
Read More
Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.
Read More